Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India. Monaldi Arch Chest Dis [Internet]. 2023 Feb. 1 [cited 2026 Apr. 17];93(4). Available from: https://www.monaldi-archives.org/macd/article/view/2449